Stock quote - Summary

Allergy Therapeutics
AGY: 32.75 +0.50 ( +1.55 %) delayed: 17:10PM
Bid price 32.50 High price 33.00
Ask price 33.00 Low price 32.30
Open price 32.25 Spread 1.52%
Prev close 32.75 Volume 628,495

Allergy Therapeutics - Share price charts

Intraday
You need to install or upgrade your Flash Player
Historic - 1 year
You need to install or upgrade your Flash Player

Advanced Allergy Therapeutics charts >

Allergy Therapeutics - Share price information
Name Allergy Therapeutics Epic AGY
Activities Allergy Therapeutics plc is a specialty pharmaceutical company focused on allergy vaccination. It has a growing business achieving revenue in the last financial year of £42 million mainly in Europe through its own sales and marketing infrastructure and further afield through distributors. The Company is expanding its infrastructure into the Emerging markets. ISIN GB00B02LCQ05
Latest Share Price (p) 32.75 Net Gearing (%) 5.20
Market Capitalisation (pm) 191.60 Gross Gearing (%) 46.50
Shares in issue (m) 594.12 Debt Ratio 31.33
P/E Ratio -14.08 Debt-to-Equity Ratio 0.53
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.87
Dividend Yield (%) 0.00 Price to book value 6.32
Dividend Cover 0.00 ROCE (%) -27.31
Earning per share (p) -2.29 EPS Growth (%) -11,550.00
52-week high / low (p) 32.75 / 16.38 DPS Growth (%) n/a
Allergy Therapeutics - Broker views
Date Broker Recommendation Price Old target price New target price Notes
22 Sep Numis Buy 45.00 45.00 Retains
18 Sep Panmure Gordon Buy - - Retains
24 Aug finnCap Buy 46.00 46.00 Reiterates
18 Jul Numis Buy 45.00 45.00 Retains
18 Jul finnCap Buy 43.00 46.00 Reiterates

More Allergy Therapeutics broker views >

Allergy Therapeutics - Director deals
Date Director Type Volume / Price Trade value
29 Sep 2016 Peter Jensen Buy 30,000 @ 19.25p £5,775.00
28 Sep 2016 Nick Wykeman Buy 150,000 @ 17.75p £26,625.00
26 Sep 2016 Manuel Llobet Buy 100,000 @ 18.00p £18,000.00
27 Jul 2015 Manuel Llobet Buy 50,000 @ 24.45p £12,225.00
10 Dec 2012 Ian Postlethwaite Sale Post-Exercise 140,000 @ 12.50p £17,500.00

More Allergy Therapeutics director deals >

Risk warning: Remember the price of shares can go down as well as up, and you are not guaranteed to get back the amount that you originally invested.
Click here to read the full warning.

Capita Asset Services is a trading name of Capita IRG Trustees Limited which is authorised and regulated by the Financial Conduct Authority and which is also authorised to conduct cross-border business within the EEA under the provisions of the EU Markets in Financial Instruments Directive. Registered office: The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU. Registered in England and Wales No. 2729260.

www.capitaassetservices.com